Additional information
| Active substance | Frag HGH 1761 |
|---|---|
| Reference | SMCTRO41 |
| Side effects | Potential to cause hyperglycemia, headaches, and feelings of lethargy |
| Effects | Reduces body fat, particularly abdominal fat |
| Dosage (sports) | 250-500 mcg per day |
| Dosage (medical) | Not established for medical use |
| Half-life | Approximately 30 minutes |
| Main action | Stimulates lipolysis and inhibits lipogenesis |
| Substance class | Peptide |
| Formula | C78H123N23O23S2 |
| Chemical name | Fragment 176-191 |
| Storage conditions | Should be stored in a cool, dry place away from light |
| ean13 | 1392806356603 |
| Dosage Unit | Ml |
| Milliliter Size | 4 Ml |
| FORM | Injection |
| Trade name | Not available under any trade names, sold as research chemical |
| Blood pressure | No significant effects reported |
| Also known as | HGH Fragment 176-191 |
| Lab Test | Specialized tests may detect peptide fragments but not commonly included in standard drug panels |
| Hepatotoxicity | None reported |
| Water Retention | None |
| Dosage | 5 Mg |
| Use in sports | Commonly used in bodybuilding for fat loss |
| Packing | Vial |
